Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
Submitted by
admin
on April 15, 2015 - 2:32pm
Source:
BioPharma Dive
News Tags:
GW Pharma
epilepsy
cannabis
Epidiolex
Headline:
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
Do Not Allow Advertisers to Use My Personal information
